SS
SLS icon

SBI Securities’s SELLAS Life Sciences SLS Stock Holding History

SBI Securities’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.2K Buy
6,384
+4,198
+192% +$29K ﹤0.01% 941
2026
Q1 		$9.25K Sell
2,186
-1,405
-39% -$6.29K ﹤0.01% 1762
2025
Q4 		$13.5K Sell
3,591
-2,135
-37% -$4.15K ﹤0.01% 1594
2025
Q3 		$9.22K Hold
5,726
– – ﹤0.01% 1805
2025
Q2 		$12.5K Buy
5,726
+298
+5% +$457 ﹤0.01% 1608
2025
Q1 		$5.86K Sell
5,428
-36
-0.7% -$43 ﹤0.01% 1837
2024
Q4 		$5.68K Buy
+5,464
New +$6.24K ﹤0.01% 1882

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

SBI Securities's SLS Position: Q2 2026 in Review

SBI Securities increased its SELLAS Life Sciences (SLS) stake by 192% in Q2 2026, buying an estimated $29K and bringing the position to 6,384 shares worth $94.2K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

SBI Securities first reported a position in SLS in Q4 2024 and has held it in 7 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • SBI Securities held 6,384 shares of SELLAS Life Sciences worth $94.2K as of Q2 2026.
  • SBI Securities bought 4,198 SELLAS Life Sciences shares in Q2 2026, an estimated $29K.
  • SELLAS Life Sciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #941 holding.
  • SBI Securities first reported a position in SELLAS Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.